VL285
CAS No. 1448188-57-5
VL285 ( —— )
Catalog No. M20084 CAS No. 1448188-57-5
VL285 is a potent VHL ligand degrading HaloTag7 fusion proteins.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 110 | In Stock |
|
10MG | 177 | In Stock |
|
25MG | 340 | In Stock |
|
50MG | 512 | In Stock |
|
100MG | 737 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVL285
-
NoteResearch use only not for human use.
-
Brief DescriptionVL285 is a potent VHL ligand degrading HaloTag7 fusion proteins.
-
DescriptionVL285 is a potent VHL ligand degrading HaloTag7 fusion proteins.
-
Synonyms——
-
PathwayPROTACs
-
TargetE3 Ligase Ligand
-
RecptorVHL
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1448188-57-5
-
Formula Weight532.65
-
Molecular FormulaC29H32N4O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 53.26 mg/mL (100 mM)
-
SMILESCC(C)[C@H](N1Cc2ccccc2C1=O)C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(cc1)-c1scnc1C
-
Chemical Name(2S4R)-4-Hydroxy-1-((S)-3-methyl-2-(1-oxoisoindolin-2-yl)butanoyl)-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Buckley DL et al. HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins. ACS Chem Biol. 2015 Aug 21;10(8):1831-7.
molnova catalog
related products
-
Pomalidomide-C2-NH2 ...
Pomalidomide-C2-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and a linker used in PROTAC technology.
-
CC-885
CC-885 (CC 885, CC885) is a novel E3 ligase cereblon (CRBN) modulator with potent anti-tumour activity mediated through the degradation of GSPT1.
-
Cereblon modulator 1
Cereblon modulator 1 is a cereblon (CRBN) E3 ligase modulator. It specifically binds to CRBN, thereby affecting the activity of the ubiquitin E3 ligase complex.